Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 266-124-4 | CAS number: 66085-00-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- GLP-Guideline study. Tested with the source substance 2,3-dihydroxypropyl oleate. According to the ECHA guidance document 'Practical guide 6: How to report read-across and categories (ECHA, 2012)', the reliability was changed from RL1 to RL2 to reflect the fact that this study was conducted on a read-across substance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 2,3-dihydroxypropyl oleate
- EC Number:
- 203-827-7
- EC Name:
- 2,3-dihydroxypropyl oleate
- Cas Number:
- 111-03-5
- IUPAC Name:
- 2,3-dihydroxypropyl octadec-9-enoate
- Details on test material:
- - Name of test material (as cited in study report): glycerol monooleate
- Physical state: light yellow pellets with characteristic odour
- Analytical purity: 99.93%
- Stability under test conditions: verified after test
Constituent 1
Method
- Target gene:
- his operon (for S. typhimurium strains)
trp operon (for E. coli strain)
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital and 5,6-benzoflavone
- Test concentrations with justification for top dose:
- -S9 mix:
4.88, 9.77, 19.5, 39.1, 78.1, 156 μg/plate (TA100, TA98)
156, 313, 625, 1250, 2500, 5000 μg/plate (TA1535, WP2 uvrA)
0.153, 0.305, 0.610, 1.22, 2.44, 4.88, 9.77 μg/ plate (TA1537)
+S9 mix:
9.77, 19.5, 39.1, 78.1, 156, 313, 625 μg/plate (TA100)
156, 313, 625, 1250, 2500, 5000 μg/plate (TA1535, WP2 uvrA, TA98)
9.77, 19.5, 39.1, 78.1, 156, 313 μg/plate (TA1537) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The test substance was not soluble in water.
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: -S9: 2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide (AF2; 0.01 or 0.1 µg/plate, TA100, TA98, E. coli); sodium azide (SA; 0.5 µg/plate, TA1535); 9-aminoacridine (9AA; 80 µg/plate, TA1537); +S9: 2-Aminoanthracene (2AA; 0.5-10 µg/plate, all strains)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: Pre-incubation method
DURATION
- Preincubation period: 20 min
- Exposure duration: 48 h
NUMBER OF REPLICATIONS: 3 replications in one experiment
DETERMINATION OF CYTOTOXICITY
- Method: Inspection of the bacterial background lawn - Evaluation criteria:
- Revertant colonies were counted for 3 plates per bacterial strain. The test result was considered positive, if the mean value out of 3 plates was at least twice as high as the negative vehicle control and a dose-dependency was found.
- Statistics:
- Mean values and standard deviation were calculated.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- -S9: at 3.13 (TA1537), 78.1 (TA98) and 100 (TA100) µg/plate and above; +S9: at 128 (TA1537) and 156 (TA100) µg/plate and above
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Water solubility: the test substance was not soluble in water.
- Precipitation: in the dose-finding studies and the main study, precipitation was observed at the end of the exposure period at ≥ 625 and ≥ 1250 µg/plate in the presence and absence of metabolic activation, respectively.
RANGE-FINDING/SCREENING STUDIES:
The highest concentrations analysed in the main study were selected based on the solubility and/or cytotoxicity of the test substance in the cell culture medium. Three dose-finding studies were performed:
[Dose-finding study]
-S9 mix: 8.19, 20.5, 51.2, 128, 320, 800, 2000, 5000 μg/plate (all strains)
+S9 mix: 8.19, 20.5, 51.2, 128, 320, 800, 2000, 5000 μg/plate (all strains)
[Dose-finding restudy]
-S9 mix: 8.19, 20.5, 51.2, 128, 320, 800, 2000, 5000 μg/plate (all strains)
+S9 mix: 8.19, 20.5, 51.2, 128, 320, 800, 2000, 5000 μg/plate (all strains)
[Dose-finding additional study]
-S9 mix
6.25, 12.5, 25.0, 50.0, 100, 200 μg/plate (TA100),
3.13, 6.25, 12.5, 25.0, 50.0, 100 μg/plate (TA98),
0.0977, 0.195, 0.391, 0.781, 1.56, 3.13, 6.25, 12.5 μg/plate (TA1537)
+S9 mix:
6.25, 12.5, 25.0, 50.0, 100, 200 μg/plate (TA1537)
ADDITIONAL INFORMATION ON CYTOTOXICITY:
The test substance was not cytotoxic to tester strains TA1535 and WP2uvrA at any concentration with and without metabolic activation.
In the dose-finding studies and in the main study, the minimum cytotoxic concentrations determined for the tester strains TA100, TA98 and TA1537 were as follows:
[Dose-finding study]
-S9 mix: 8.19 (TA1537) and 128 (TA100) μg/plate
+S9 mix: 128 (TA1537) and 320 (TA100) μg/plate
[Dose-finding restudy]
-S9 mix: 8.19 (TA1537), 51.2 (TA98) and 128 (TA100) μg/plate
+S9 mix: 128 (TA1537), 320 (TA100) μg/plate
[Dose-finding additional study]
-S9 mix: 3.13 (TA1537) and 100 (TA100, TA98) μg/plate
+S9 mix: 200 (TA1537) μg/plate
[Main study]
-S9 mix: 4.88 (TA1537), 78.1 (TA98) and 156 (TA100) µg/plate
+S9 mix: 156 (TA100) and 313 (TA1537) µg/plate - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 1. Results of the bacterial reverse mutation test
With or without S9-Mix |
Test substance concentration (μg/plate) |
Mean number of revertant colonies per plate (average of 3 plates ± standard deviation) |
||||
Base-pair substitution type |
Frameshift type |
|||||
TA 100 |
TA1535 |
WP2urvA |
TA98 |
TA1537 |
||
– |
0 |
129 ± 7 |
13 ± 2 |
25 ± 5 |
21 ± 2 |
9 ± 1 |
– |
0.153 |
|
|
|
|
9 ± 2 |
– |
0.305 |
|
|
|
|
7 ± 1 |
– |
0.610 |
|
|
|
|
9 ± 1 |
– |
1.22 |
|
|
|
|
12 ± 1 |
– |
2.44 |
|
|
|
|
7 ± 2 |
– |
4.88 |
129 ± 5 |
|
|
21 ± 1 |
10 ± 2* |
– |
9.77 |
139 ± 4 |
|
|
18 ± 3 |
10 ± 3* |
– |
19.5 |
125 ± 5 |
|
|
20 ± 4 |
|
– |
39.1 |
134 ± 3 |
|
|
17 ± 2 |
|
– |
78.1 |
142 ± 6 |
|
|
18 ± 3* |
|
– |
156 |
131 ± 6 * |
12 ± 2 |
16 ± 3 |
24 ± 6* |
|
– |
313 |
10 ± 3 |
22 ± 3 |
|
|
|
– |
625 |
12 ± 2 |
21 ± 4 |
|
|
|
– |
1250 (+) |
10 ± 2 |
16 ± 2 |
|
|
|
– |
2500 (+) |
10 ± 2 |
16 ± 2 |
|
|
|
– |
5000 (+) |
|
9 ± 1 |
13 ± 3 |
|
|
Positive controls, –S9 |
Name |
AF2 |
SA |
AF2 |
AF2 |
9AA |
Concentrations (μg/plate) |
0.01 |
0.5 |
0.01 |
0.1 |
80 |
|
Mean No. of colonies/plate (average of 3 plates ± SD) |
886 ± 5 |
549 ± 8 |
148 ± 19 |
689 ± 53 |
200 ±7 |
|
+ |
0 |
121 ± 4 |
13 ± 1 |
26 ± 5 |
29 ± 1 |
25 ± 3 |
+ |
9.77 |
132 ± 7 |
|
|
|
20 ± 2 |
+ |
19.5 |
130 ± 6 |
|
|
|
20 ± 2 |
+ |
39.1 |
125 ± 8 |
|
|
|
21 ± 2 |
+ |
78.1 |
121 ± 4 |
|
|
|
13 ± 4 |
+ |
156 |
123 ± 4* |
14 ± 0 |
25 ± 4 |
24 ± 3 |
12 ± 2 |
+ |
313 |
118 ± 5* |
12 ± 2 |
19 ± 5 |
25 ± 3 |
10 ± 2* |
+ |
625 (+) |
106 ± 8* |
13 ± 2 |
23 ± 4 |
26 ± 6 |
|
+ |
1250 (+) |
|
8 ± 2 |
16 ± 2 |
19 ± 3 |
|
+ |
2500 (+) |
|
9 ± 1 |
16 ± 2 |
19 ± 1 |
|
+ |
5000 (+) |
|
11 ± 1 |
16 ± 2 |
12 ± 2 |
|
Positive controls, +S9 |
Name |
2AA |
2AA |
2AA |
2AA |
2AA |
Concentrations (μg/plate) |
1 |
2 |
10 |
0.5 |
2 |
|
Mean No. of colonies/plate (average of 3 plates ± SD) |
1018 ± 35 |
336 ± 19 |
732 ± 65 |
370 ± 10 |
142 ± 5 |
(+): Visible precipitation was observed at the end of exposure period.
*: Growth inhibition was observed
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.